Results 1 to 10 of about 67,109 (166)

The melanocortin receptors as targets for general obesity: contextualizing clinical failures and analyzing future perspectives [PDF]

open access: yesFrontiers in Endocrinology
The melanocortin system is a genetically conserved and clinically validated target for the treatment of obesity. Hundreds of studies establish the role of the melanocortin receptors, particularly the melanocortin-4 receptor, in food intake, weight ...
Claudia R. Prindle   +7 more
doaj   +2 more sources

Development of a genetically encoded melanocortin sensor for high sensitivity in vivo imaging [PDF]

open access: yesMolecular Metabolism
Objective: The central melanocortin system, composed of peptides derived from pro-opiomelanocortin (POMC) such as the melanocyte-stimulating hormones (α-, β-, γ-MSH) and melanocortin 4 receptors (MC4R), along with the agouti-related protein (AgRP), plays
Yoon Namkung   +6 more
doaj   +2 more sources

Melanocortin System in Kidney Homeostasis and Disease: Novel Therapeutic Opportunities

open access: yesFrontiers in Physiology, 2021
Melanocortin peptides, melanocortin receptors, melanocortin receptor accessory proteins, and endogenous antagonists of melanocortin receptors are the key components constituting the melanocortin hormone system, one of the most complex and important ...
Mingyang Chang   +4 more
doaj   +1 more source

Evidence for an interaction between cannabinoidergic and dopaminergic systems with melanocortin MC3/ MC4 receptors in regulating food intake of neonatal chick [PDF]

open access: yesThe Iranian Journal of Veterinary Science and Technology, 2021
The current study aimed to see how the central dopaminergic and cannabinoidergic mechanisms affect melanocortin-induced food intake in the neonatal layer chickens. In this regard, 9 experiments were designed. In experiment 1, chicks injected with control
Mohammad Bameri   +4 more
doaj   +1 more source

Melanocortin therapies to resolve fibroblast-mediated diseases

open access: yesFrontiers in Immunology, 2023
Stromal cells have emerged as central drivers in multiple and diverse diseases, and consequently, as potential new cellular targets for the development of novel therapeutic strategies.
Natalya Khodeneva   +3 more
doaj   +1 more source

Melasma Clinical Features, Diagnosis, Epidemiology and Etiology: An Update Review

open access: yesSiriraj Medical Journal, 2021
Melasma is one of the commonest dermatological challenges that facing dermatologists in the whole world. Most of the previously published articles regarding melasma usually focused on its management and the newly discovered drugs; however, the ...
Mohammad Ahmad Abdalla
doaj   +1 more source

A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans

open access: yesFrontiers in Immunology, 2023
IntroductionPL8177 is a potent and selective agonist of the melanocortin 1 receptor (MC1R). PL8177 has shown efficacy in reversing intestinal inflammation in a cannulated rat ulcerative colitis model.
John Dodd   +8 more
doaj   +1 more source

Differential Signaling Profiles of MC4R Mutations with Three Different Ligands [PDF]

open access: yes, 2020
The melanocortin 4 receptor (MC4R) is a key player in hypothalamic weight regulation and energy expenditure as part of the leptin-melanocortin pathway. Mutations in this G protein coupled receptor (GPCR) are the most common cause for monogenetic obesity,
Annibale, Paolo   +8 more
core   +3 more sources

Impact of the Central Histaminergic and Melanocortin Systems on Leptin-Induced Hypophagia in Neonatal Layer Chicken [PDF]

open access: yesArchives of Razi Institute, 2021
The present study aimed to assess the probable impact of the central histaminergic and melanocortin systems on leptin-induced hypophagia in neonatal layer chickens.
M Shalikar   +3 more
doaj   +1 more source

Melanocortin 4 receptor signaling in Sim1 neurons permits sexual receptivity in female mice

open access: yesFrontiers in Endocrinology, 2023
IntroductionFemale sexual dysfunction affects approximately 40% of women in the United States, yet few therapeutic options exist for these patients. The melanocortin system is a new treatment target for hypoactive sexual desire disorder (HSDD), but the ...
Erin A. Semple   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy